Sone-191 High Quality -

• Fibrosis and chronic inflammation are driven by sustained activation of immune cells, profibrotic signaling (e.g., TGF-β), and extracellular matrix deposition. Therapies that modulate immune responses or inhibit profibrotic signaling can slow or reverse pathological tissue remodeling.
• SONE-191 was designed to intervene in one or more of these pathogenic nodes (reports describe effects on inflammatory cytokine production and markers of fibroblast activation in preclinical models).

4. Performance Highlights

| Metric | Result (Typical) | Comparison | |--------|------------------|------------| | Peak MAC throughput | 1.5 TOPS (Tera‑operations per second) | 2× faster than leading FPGA‑based DSPs | | End‑to‑end latency (5G NR PDSCH) | 0.73 µs (including I/O) | Meets 3GPP “Ultra‑Low Latency” target (≤1 µs) | | Power efficiency | 0.85 TOPS/W | 30 % improvement over contemporary ASICs | | Memory bandwidth utilization | 95 % sustained | Near‑theoretical HBM2e limit | | Dynamic reconfiguration time | < 10 ms for a 64‑core sub‑pipeline | Far faster than full FPGA re‑program (≥200 ms) |

4.2 Next‑Generation EVs

Automakers have long been constrained by lithium‑supply volatility and the weight penalty of larger packs. A 500 km range on a 60 kWh SONE‑191 pack translates to a ~25 % weight reduction versus an equivalent Li‑ion pack. Moreover, the fast‑charge capability (0‑80 % in 12 min)—enabled by the high ionic conductivity of the solid electrolyte—meets consumer expectations for “gas‑station‑like” charging. SONE-191